GlassScriptPhysician profile
Jose M Cabral
NPI 1457314817
$33,884.37
in general payments reported to CMS, 2019-2025
16 companies · $515 in 2025
The $515 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $3,231 · 2021: $12K · 2022: $198 · 2023: $352 · 2024: $320 · 2025: $515.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,188.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $31,898.27 | 2019-2023 | |
| Dexcom, INC. | $628.72 | 2019-2023 | Dexcom G6 Transmitter |
| Insulet Corporation | $459.03 | 2019-2025 | Omnipod |
| Medtronic, INC. | $301.17 | 2021-2025 | Minimed 780g |
| Novo Nordisk INC | $158.30 | 2019-2025 | Ozempic, Rybelsus |
| Tandem Diabetes Care, INC. | $101.21 | 2024-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Sequel Med Tech, LLC | $61.55 | 2025 | Twiist |
| Lifescan, INC. | $52.20 | 2019-2021 | |
| Lilly USA, LLC | $40.30 | 2022-2025 | Zepbound, Mounjaro |
| Janssen Scientific Affairs, LLC | $39.24 | 2023 | Xarelto |
| Janssen Pharmaceuticals, INC | $35.23 | 2019 | |
| Beta Bionics, INC. | $34.58 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Ascendis Pharma Endocrinology INC | $28.69 | 2025 | Yorvipath |
| Xeris Pharmaceuticals, INC. | $16.44 | 2024 | Recorlev |
| Amgen INC. | $16.04 | 2025 | Evenity, Prolia |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Minimed, INC. | $13.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Cabral listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.